Breast cancer progression may be halted with CRISPR gene editing
A tumour-targeted CRISPR gene editing system encapsulated in a nanogel could halt the growth of triple-negative breast cancer.
List view / Grid view
A tumour-targeted CRISPR gene editing system encapsulated in a nanogel could halt the growth of triple-negative breast cancer.
The structure of a key receptor involved in tumour metastasis has been imaged in a study, providing opportunities to develop cancer treatments.
Libraries of more than 9,000 macrocyclic molecules below 1 KDa have been generated, small enough to cross cell membranes and reach targets.
A pharmaceutical target has been identified by Duke University that, when activated, can reverse bone degradation caused by osteoporosis.
A new platform has enabled an unprecedented level of control over individual molecules and particles on a chip for high-throughput analysis.
Designing new drug molecules is crucial to R&D. Dr Sam Genway suggests that one way to improve and speed up this process is using AI inspired by language translation.
A molecular switch that impacts immune responses to viral infections has been identified which could lead to better strategies to develop vaccines.
Molecular Devices, LLC, today announced the launch of the next generation of its FLIPR® Penta High-Throughput Cellular Screening System.
New discovery makes it possible to design new therapies to replace alpha-synuclein's function in people with Parkinson's disease.
A new study shows that the activity of p38 is important in MSCs, which can localise around blood vessels.
Using human data, a new study has examined how Cryptococcus genes impact patients with Cryptococcus Neoformans.
Researchers have developed a chip which facilitates and accelerates active substance production, characterisation and biological effectiveness.
A new 'optochemogenetics' research approach from scientists at the Emory University School of Medicine could aid in helping stroke victims.
Pharmaceutical company, Sanofi, will eliminate jobs in France and Germany and end new in-house cardiology research programmes.
Redundancies have been discovered in the biochemical signalling pathways of immune cells which could impact cancer immunotherapy.